Action of Amantadine on Post-Stroke Aphasic Patients "CELIC-1"

Completed

Phase 2/3 Results N/A

Summary of Purpose

The objective of the study is to test the action of the amantadine, as DOPA-agonist, in a double blind cross-over trial, amantadine / placebo, on the verbal fluency of chronic post stroke aphasic patients.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 18 April 2014.

1 Mar 2009 9 Jan 2009 1 Apr 2013 1 Apr 2013 1 Jun 2013 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator)
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Crossover Assignment

Contacts